Fri, Dec 19, 2014, 4:06 AM EST - U.S. Markets open in 5 hrs 24 mins

Recent

% | $
Quotes you view appear here for quick access.

Ampio Pharmaceuticals, Inc. Message Board

benwilliams1942 6 posts  |  Last Activity: Dec 4, 2014 1:40 PM Member since: Jun 7, 2013
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • benwilliams1942 benwilliams1942 Nov 17, 2014 10:21 AM Flag

    According to the UNiversity of Alberta and the "New Technology" oil patch trade journal, the AOS Filter is very likely to have an enormous positive impact on the oil industry and the water treatment industry. BLGO shares are $.50 cents

    Sentiment: Strong Buy

  • Reply to

    BioLargo Is On the Oil Industry’s Radar Again

    by stocks4show Nov 13, 2014 11:32 AM
    benwilliams1942 benwilliams1942 Nov 18, 2014 1:16 PM Flag

    Amazing technology that will have very big impact on oil industry and water treatment industry

    Sentiment: Strong Buy

  • Millennium Healthcare (MHCC) just reported $6.3 million, a 1,200% increase in revenues in its recent 10Q filing.

    Because Millennium’s diagnostics are preventive, FDA approved, reimbursable and cost patients little to nothing, and because they add significant income for physicians, sales are beginning to increase exponentially.

    Millennium’s gross margins are exceptionally high as the equipment and associated costs typically pays for themselves in the first 30 days of installation.

    Millennium’s network is projected to grow dramatically and sales and earnings are in the early part of a steep growth curve.

    $6.3 million was achieved with only a small number of Millennium’s the current 1,300 physician offices.

    There are over 30,000 primary care offices.

    Millennium has the potential to sign a large number of the 30,000 plus offices.

    At 40 cents Millennium shares are a ground floor opportunity.

    Shares are exceptionally cheap because the company has paid many bills with shares of stock that have depressed shares prices because they have been sold over the past several months.

    Invest a few minutes of your time to read the 10Q for yourself and confirm an exceptional opportunity.

    MHCC is a very strong buy!

    Sentiment: Strong Buy

  • Millennium Healthcare (MHCC) just reported $6.3 million, a 1,200%+ increase in revenues in its recent 10Q filing.

    Existing and growing revenues reduce risk dramatically.

    Because Millennium’s diagnostics are preventive, FDA approved, reimbursable and cost patients little to nothing, and because they add significant income for physicians, sales are beginning to increase exponentially. Future growth is unusually large.

    And Millennium’s gross margins are exceptionally high as the equipment and associated costs can pay for themselves in the first 30 days of installation.

    Millennium’s network of 1,300 physician offices is projected to grow dramatically and sales and earnings are in the early part of a steep growth curve.

$6.3 million was achieved with only a small number of Millennium’s the current 1,300 physician offices.

    There are over 30,000 primary care offices.

Millennium has the potential to sign a large number of the 30,000 plus offices.

    At 20-40 cents Millennium shares are a ground floor opportunity.

    Shares are oversold and exceptionally cheap because the company has paid millions in fees (reported in 10Q) to consultants with shares of stock that they have been selling heavily to convert to cash. This heavy selling has depressed shares prices to a very attractive entry point.

    Invest a few minutes of your time to read the 10Q for yourself and confirm an exceptional opportunity.

MHCC 12 month target - $6.00.

    Sentiment: Strong Buy

  • Millennium Healthcare (MHCC) just reported $6.3 million, a 1,200%+ increase in quarter revenues in its recent 10Q filing.

    Because Millennium’s diagnostics are preventive, FDA approved, reimbursable and cost patients little to nothing, and because they add significant income for physicians, sales are beginning to increase exponentially. Future growth is unusually large.

    And Millennium’s gross margins are exceptionally high as the equipment and associated costs can pay for themselves in the first 30 days of installation.

    Millennium’s network of 1,300 physician offices is projected to grow dramatically and sales and earnings are in the early part of a steep growth curve.

    $6.3 million was achieved with only a small number of Millennium’s the current 1,300 physician offices.

    There are over 30,000 primary care offices.

    Millennium has the potential to sign a large number of the 30,000 plus offices.

    At 20-40 cents Millennium shares are a ground floor opportunity.

    Shares are oversold and exceptionally cheap because the company has paid millions in fees (reported in 10Q) to consultants with shares of stock that they have been selling heavily to convert to cash. This heavy selling has depressed shares prices to a very attractive entry point.

    Invest a few minutes of your time to read the 10Q for yourself and confirm an exceptional opportunity.

    MHCC 12 month target - $6.00.

    Sentiment: Strong Buy

  • Millennium Healthcare (MHCC) just reported $6.3 million, a 1,200%+ increase in quarter revenues in its recent 10Q filing.

    Because Millennium’s diagnostics are preventive, FDA approved, reimbursable and cost patients little to nothing, and because they add significant income for physicians, sales are beginning to increase exponentially. Projected growth is remarkable.

    And Millennium’s gross margins are exceptionally high as the equipment and associated costs can pay for themselves in the first 30 days of installation.

    Millennium’s network of 1,300 physician offices is growing dramatically and sales and earnings are in the early part of a steep growth curve. There are over 30,000 primary care offices and most of them are going to want MHCC exclusive diagnostics.

    $6.3 million was achieved with only a small number of Millennium’s the current 1,300 physician offices.

    Millennium has the potential to sign a large number of the 30,000 plus offices.

    At 30-50 cents Millennium shares are a ground floor opportunity.

    Shares are oversold and exceptionally cheap because the company has paid millions in fees (reported in 10Q) to consultants with shares of stock that they have been selling heavily to convert to cash. This heavy selling has depressed shares prices to a very attractive entry point.

    Invest a few minutes of your time to read the 10Q for yourself and confirm an exceptional buying opportunity.

    Recommend taking advantage of current tax selling low price and putting into your portfolio now.

    MHCC 12 month target - $6.00

    Sentiment: Strong Buy

AMPE
3.64+0.07(+1.96%)Dec 18 4:05 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Oracle Corporation
NYSEThu, Dec 18, 2014 4:00 PM EST
NQ Mobile Inc.
NYSEThu, Dec 18, 2014 4:05 PM EST